Corporate Tech Investors

Kite Pharma

Kite Pharma is a corporate VC investing group that partners with firms that align with the company's business objectives.

Venture Investor Overview

Contact Information

Background Information

Overview

To bring about this transformation, we're developing innovative products that harness a patient's own immune system to target and attack cancer cells. In just three years, our singular focus and strategic collaborations, including multiple Cooperative Research and Development Agreements with the National Cancer Institute, have enabled us to advance an industry-leading pipeline of chimeric antigen receptor (CAR) and T cell receptor (TCR) product candidates to address both hematological (blood-based) and solid cancers.

Profile

Social Media

Company News

Facebook

YouTube

Last Transaction

5/16/2023

Transaction History

Our records indicate that Kite Pharma invested in the VC transactions listed below. Dollar amounts are for the entire raise, which may include other investors.

Investor Contacts

Title

Name

Email & Social

Chief Executive Officer

Christi Shaw

        

Funds

No fund closings have been recorded for this company.

Portfolio Companies

Kite Pharma has invested in the companies below, according to our database records. If we are missing a portfolio company, please let us know.

Browse more corporate investors:

Kissei Pharmaceutical | KiwiTech

Share this article

About Our Corporate Tech Investor Database

This corporate tech investor profile is powered by VentureDeal.com, a leading provider of corporate tech investing transaction data.

Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary